Literature DB >> 32169890

Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor-Host Feedback Signaling.

Iris Kamer1, Inbal Daniel-Meshulam1, Oranit Zadok1, Elizabeta Bab-Dinitz1, Gili Perry1, Rotem Feniger-Barish1, Marina Perelman2, Iris Barshack2,3, Alon Ben-Nun3,4, Amir Onn5, Jair Bar6,3.   

Abstract

Tumor-host interactions play a major role in malignancies' initiation and progression. We have reported in the past that tumor cells attenuate genotoxic stress-induced p53 activation in neighboring stromal cells. Herein, we aim to further elucidate cancer cells' impact on signaling within lung cancer stroma. Primary cancer-associated fibroblasts were grown from resected human lung tumors. Lung cancer lines as well as fresh cultures of resected human lung cancers were used to produce conditioned medium (CM) or cocultured with stromal cells. Invasiveness of cancer cells was evaluated by transwell assays, and in vivo tumor growth was tested in Athymic nude mice. We found CM of a large variety of cancer cell lines as well as ex vivo-cultured lung cancers to rapidly induce protein levels of stromal-MDM2. CM of nontransformed cells had no such effect. Mdm2 induction occurred through enhanced translation, was mTORC1-dependent, and correlated with activation of AKT and p70 S6 Kinase. AKT or MDM2 knockdown in fibroblasts reduced the invasion of neighboring cancer cells, independently of stromal-p53. MDM2 overexpression in fibroblasts enhanced cancer cells' invasion and growth of inoculated tumors in mice. Our results indicate that stromal-MDM2 participates in a p53-independent cancer-host feedback mechanism. Soluble cancer-originated signals induce enhanced translation of stromal-MDM2 through AKT/mTORC1 signaling, which in turn enhances the neighboring cancer cells' invasion ability. The role of these tumor-host interactions needs to be further explored. IMPLICATIONS: We uncovered a novel tumor-stroma signaling loop, which is a potentially new therapeutic target in lung cancer and possibly in additional types of cancer. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32169890     DOI: 10.1158/1541-7786.MCR-19-0395

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  3 in total

Review 1.  It's Getting Complicated-A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy.

Authors:  Che-Pei Kung; Jason D Weber
Journal:  Front Cell Dev Biol       Date:  2022-01-26

2.  HAX1 enhances the survival and metastasis of non-small cell lung cancer through the AKT/mTOR and MDM2/p53 signaling pathway.

Authors:  Zhigang Liang; Yuan Zhong; Lifei Meng; Yi Chen; Yahui Liu; Aihua Wu; Xinjian Li; Mingsong Wang
Journal:  Thorac Cancer       Date:  2020-09-14       Impact factor: 3.500

3.  Coal dust exposure triggers heterogeneity of transcriptional profiles in mouse pneumoconiosis and Vitamin D remedies.

Authors:  Min Mu; Bing Li; Yuanjie Zou; Wenyang Wang; Hangbing Cao; Yajun Zhang; Qixian Sun; Haoming Chen; Deyong Ge; Huihui Tao; Dong Hu; Liang Yuan; Xinrong Tao; Jianhua Wang
Journal:  Part Fibre Toxicol       Date:  2022-01-20       Impact factor: 9.400

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.